About Timothy Edwards
Timothy Edwards is a chairperson, independent at Endlyz Therapeutics.
Experience
This experience comes from Timothy Edwards's profile and from SEC filings. For roles taken from filings, the years are when the filings name Timothy Edwards in the role, so the role may have started earlier or lasted longer.
QI
Quadram Institute Current
Board Trustee
2026 – Present
SE
SENISCA Current
Chair
2024 – Present
Endlyz Therapeutics, Inc. Current
Chairperson, Independent
2021 – Present · Boston, MA
Develops potential medicines for people with Parkinson’s disease and other dementias.
SP
Schroders Capital Global Innovation Trust plc Current
Chair
2021 – Present
II
Institute for Research in Schools (IRIS) Current
Chair
2018 – Present
SL
STORM Therapeutics Limited Current
Chair
2015 – Present
AT
AstronauTx Therapeutics
Chair
2019 – 2025
RP
Record PLC
Senior Independent Director (SID)
2018 – 2024
ML
Modulus Oncology Ltd.
Chair
2021 – 2022
KL
Karus Therapeutics Limited
Chair
2019 – 2021
EB
Enara Bio
Director
2017 – 2020
MO
Magdalen College School, Oxford
Governor (former Chair)
2012 – 2020
TL
TRex Bio Limited
Director
2018
IU
Innovate UK
Member of Governing Body
2015 – 2018
AL
Atopix Therapeutics Limited
Executive Chairman
2012 – 2016
CC
Cell Therapy Catapult
Non-Executive Director
2013 – 2015
TS
The Mulberry Bush School
Chair of Trustees
2005 – 2015
BA
BioIndustry Association
Chair and Board member
2007 – 2014
PA
ProtAffin AG
Supervisory Board Member
2011 – 2013
CI
Cellzome Inc
President and CEO
2003 – 2012
Key Colleagues at Startups
The people Timothy Edwards works with at each company, as listed on that company's latest Form D.
Endlyz Therapeutics, Inc. · Form D, May 7, 2026
JF
Justian Fox
Director
Donmienne Leung
Director, AbbVie Ventures
Laurence Barker
Partner, SV Health Investors and director
Joanna Wolak
CEO and Co-founder, director